Immusol, Inc. Changes Name to ItherX, Names New CEO
12/17/2007 7:19:25 AM
More...
|
BioInvent And Immusol, Inc. To Collaborate On Antibody Therapeutic For Macular Degeneration
4/3/2006 5:23:03 PM
More...
|
Immusol, Inc. Announces An Exclusive Worldwide License Agreement With Baylor College of Medicine For A Novel Cancer Therapy
2/1/2006 2:54:25 PM
More...
|
Immusol, Inc. Announces Appointment Of Chief Financial Officer
10/19/2005 5:10:51 PM
More...
|
Immusol, Inc. Announces Two Management Appointments
10/19/2005 5:09:45 PM
More...
|
Clark F. Springgate, M.D., Ph.D. Named Immusol, Inc. Vice President Of Clinical And Regulatory
10/19/2005 5:09:43 PM
More...
|
Former Genentech (DNA) Veteran Joins Immusol, Inc. To Advance Therapeutic Development Efforts
10/19/2005 5:09:43 PM
More...
|
Immusol, Inc. Announces Research Collaboration With Peking University To Develop Therapeuic Compounds
10/19/2005 5:09:11 PM
More...
|
Immusol, Inc. Announces License Agreement For Wet AMD Target With The University of Kentucky
10/19/2005 5:09:09 PM
More...
|
Immusol, Inc. Announces Collaboration With Novartis Corporation (NVS)
10/19/2005 5:09:09 PM
More...
|
|